Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care
Recommendations
As issued by the authors
Enable people who can self-manage and are willing and capable of using continuous subcutaneous insulin infusion (CSII) to continue doing so as they would out of hospital
Discontinue CSII if the individual is critically ill or hemodynamically unstable
Hybrid closed-loop systems should be discontinued from auto-mode and may be used individually (as continuous glucose monitoring (CGM) only or CSII only, if criteria are met)
Continue closed-loop mode only under specialist guidance from the Diabetes Team, where teams are comfortable and knowledgeable about the specific devices
Health care organizations need clear local policies and guidance, and a capable, skilled workforce to ensure safe use in hospital
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →